An old drug gets a new price to fight a rare disease: $89,000 a year

iStock
An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. Though not previously approved in the United States, the drug, deflazacort, has for years been available to patients suffering...

Read full post here:
https://skpsoft.com/business/an-old-drug-gets-a-new-price-to-fight-a-rare-disease-89000-a-year/